>
CIA Analyst Larry Johnson: US and Iran Back at War! What Happens Next? LIVE
Scott Ritter's Shocking Report From Inside Russia
Regenerative Farming Executive Order
Bill C-8 IS NOW LAW: Canada's WARRANTLESS SURVEILLANCE NIGHTMARE Explained!!
'Groundbreaking' Potential Lupus Cure Sends Patients into Remission, Allowing Dreams...
Speculations on What Could Show Physics Beyond the Standard Model
SpaceX Orbital Travel and Orbital Hotels Need Starfall – Getting Back Safe and Cheap is Exciting
Lizard-inspired wiggly wheels let Mars rover swim through sand
Fact Sheet: President Donald J. Trump Ushers in the Next Frontier of Quantum Innovation
Researchers at Johns Hopkins University just let an AI-guided robot remove a dead pig's gallblad
World's first consumer wing-in-ground effect aircraft takes flight
America's Military Readiness Depends On Deployable Nuclear Power
License Plate Cameras Are About To Start Tracking A Lot More Than Just Your Car
Heads up: Apparently the government is hiding cameras inside fake utility boxes

A groundbreaking study published in the Journal of Biomolecular Structure and Dynamics suggests just that — revealing how a natural compound found in licorice root might be a powerful weapon against breast cancer.
The sweet science behind glycyrrhizin
Glycyrrhizin, the active ingredient in licorice root responsible for its sweetness, has been used for centuries in traditional medicine to treat everything from sore throats to digestive issues. But now, researchers are uncovering its potential as a natural cancer-fighting agent. (Related: Licorice contains powerful cancer-killing phytochemicals.)
Using advanced computer modeling and bioinformatics — a subdiscipline of biology and computer science that uses software tools to analyze and interpret biological data — Iranian researchers mapped out exactly how this compound interacts with breast cancer cells, and the results are promising.
The study dug deep into the molecular pathways glycyrrhizin takes to combat cancer. Specifically, it focused on the breast cancer genes glycyrrhizin targets and how the compound interacts with the genes' protein products.
Of the 10 breast cancer-related genes the researchers looked at, they found that glycyrrhizin showed the highest binding affinity to three genes, namely, POLK, TBXAS1 and ADRA1A. These genes are active in three types of breast cancer: breast carcinoma, malignant neoplasm of the breast and triple-negative breast neoplasms.
The researchers reported that the protein products of these genes "had an association with [breast cancer] at several stages of tumor growth." By binding to and influencing the activities of these targets, glycyrrhizin is able to influence and control breast cancer growth and survival efficiently.
Molecular dynamics simulation also revealed that of the three interactions mapped out by the study, the destructive pathways triggered by glycyrrhizin's binding to ADRA1A had the highest likelihood of occurring.